Premethylenomycin C lactone

Premethylenomycin C lactone
Clinical data
ATC code
  • none
Identifiers
  • (3aS,6aS)-4,5-dimethyl-3a,6a-dihydro-1H-cyclopenta[c]furan-3,6-dione
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC9H10O3
Molar mass166.176 g·mol−1
3D model (JSmol)
  • O=C1[C@@]2([C@](C(C)=C1C)(C(=O)OC2)[H])[H]
  • InChI=1S/C9H10O3/c1-4-5(2)8(10)6-3-12-9(11)7(4)6/h6-7H,3H2,1-2H3/t6-,7-/m1/s1
  • Key:JWRKRFZYNNBFNA-RNFRBKRXSA-N

Premethylenomycin C lactone is a natural product with potent antibiotic activity, effective in vitro against drug-resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).‍[1][2]

Discovery

The compound was identified unintentionally during investigations of the methyl­eno­mycin biosynthetic gene cluster in Streptomyces coelicolor, a bacterium found in soil.‍[1] Genetic blockade of a specific enzymatic step by deletion of the mmyE gene led to the accumulation and isolation of previously un­character­ized intermediates, including pre­methyl­eno­mycin C and its lactone derivative.‍[2][3]

In the biosynthetic pathway that produces methyl­eno­mycin A, pre­methyl­eno­mycin C lactone is an early inter­mediate. Hydrolysis of the lactone ring followed by dehydration yields methyl­eno­mycin C, which is subsequently oxidized to form the epoxide methyl­eno­mycin A.‍[2]

Bioactivity

Compared with methylenomycin A and methyl­eno­mycin C, pre­methyl­eno­mycin C and its lactone precursor exhibit anti­microbial activity one to two orders of magnitude greater against a range of Gram-positive bacteria, including anti­biotic-resistant isolates of Staphylococcus aureus and Enterococcus faecium.‍[2] They also do not have the α-methylene-γ-butyro­lactone pharma­co­phore of methyl­eno­mycin A and C, implying they have a different mode of action.‍[2] These properties highlight the compounds in this metabolic series as potential lead structures for developing new antibiotics to combat anti­microbial resistance.‍[2]

Chemistry

Beyond its natural production, pre­methyl­eno­mycin C lactone can be prepared synthetically via a dia­stereo­selective, phosphine-mediated (3 + 2) cyclo­addition reaction, providing a route for larger‑scale preparation and structure–activity relationship studies.‍[4]

References

  1. ^ a b Naddaf M (October 2025). Skipper M (ed.). "Powerful new antibiotic that can kill superbugs discovered in soil bacteria". Nature. doi:10.1038/d41586-025-03595-3. ISSN 1476-4687. LCCN 12037118. OCLC 01586310. PMID 41174166. CODEN NATUAS.
  2. ^ a b c d e f Corre C, Idowu GA, Song L, Whitehead ME, Alkhalaf LM, Challis GL (November 2025). Carreira EM (ed.). "Discovery of Late Intermediates in Methylenomycin Biosynthesis Active against Drug-Resistant Gram-Positive Bacterial Pathogens". Journal of the American Chemical Society. 147 (44): 40554–40561. Bibcode:2025JAChS.14740554C. doi:10.1021/jacs.5c12501. ISSN 1520-5126. LCCN 16003159. OCLC 01226990. PMC 12593393. PMID 41145303. CODEN JACSAT.
  3. ^ Adams B (28 October 2025). "Warwick University scientists help find 'hidden' antibiotic". BBC News.
  4. ^ Wright AI, Zhang C, Cao J, Nakano Y, Sánchez-Jiménez L, DeBono J, et al. (August 2025). Miller SJ (ed.). "Phosphine-Mediated (3 + 2) Cycloaddition of Electron-Poor Terminal Alkynes: A Concise Route to Premethylenomycin C Lactone". The Journal of Organic Chemistry. 90 (31). ACS Publications: 11230–11236. doi:10.1021/acs.joc.5c01179. ISSN 1520-6904. LCCN 38005884. PMID 40728462. CODEN JOCEAH.

Further reading